Cowden syndrome. Managing multiple skeletal metastases of different origin: a case report by unknown
BioMed CentralCases Journal
ssOpen AcceCase Report
Cowden syndrome. Managing multiple skeletal metastases of 
different origin: a case report
Antonios Angoules1, Evangelia Maria Tsapakis2, Ioannis Polyzois1, 
Zakareya Gamie1, James Julian Rankine1 and Eleftherios Tsiridis*1
Address: 1Academic Orthopaedic Unit, Leeds General Infirmary, Leeds School of Medicine, Leeds, LS1 3EX, UK and 2Institute of Psychiatry, King's 
College London, London, UK
Email: Antonios Angoules - antangules@med.uoa.gr; Evangelia Maria Tsapakis - Eva-Maria.Tsapakis@iop.kcl.ac.uk; 
Ioannis Polyzois - polyzois@hotmail.co.uk; Zakareya Gamie - ugm1zg@gmail.com; James Julian Rankine - james.rankine@leedsth.nhs.uk; 
Eleftherios Tsiridis* - etsiridis@doctors.org.uk
* Corresponding author    
Abstract
Background: Cowden Syndrome is a rare autosomal dominant multiple hamartomatous
condition, characterised by both benign and malignant tumours affecting multiple systems.
Case presentation: We present a 47-year-old female patient with thigh pain that was diagnosed
with Cowden syndrome 20 years ago and developed multiple and different skeletal metastases
which became resistant to radio-chemotherapy. A percutaneous plate fixation of the distal femur
with an intralesional excision and cementoplasty of the metastasis was performed initially. This was
combined with a cemented total hip arthroplasty using an Exeter long revision stem and a
cementoplasty of the femoral canal for the proximal lesions.
Conclusion: A meticulous approach to her complex metastatic disease resulted in successful
palliative prophylactic reconstructive surgery that improved her quality of life, allowing her
independent pain free walking for 12 months.
Background
Cowden Syndrome (CS) is a rare autosomal dominant
disorder characterised by multiple hamartomas and an
increased risk of breast, thyroid and endometrial carcino-
mas [1,2] Germline mutations in the tumour suppressor
gene PTEN (phosphatase and tensin homolog) chromo-
some 10q23.2, which codes for a lipid phosphate mediat-
ing cell cycle arrest and apoptosis, were first described in
Cowden Syndrome[3] In the next years since PTEN had
been identified as the major CS susceptibility gene[4], a
number of inherited cancer and developmental syn-
dromes were associated with germline PTEN mutations. It
has therefore been proposed that all such syndromes
based on molecular defects are classified as PTEN Hamar-
toma Tumour Syndromes (PHTS)[2,5]. Irrespective of
clinical phenotype however, the discovery of a germline
PTEN mutation should trigger cancer risk surveillance[6].
Skeletal metastases of multiple origins are difficult to treat
and palliative surgery usually requires a combination of
approaches and techniques.
Case presentation
A 47-year-old female Caucasian patient presented with a
right sided limp and ipsilateral thigh pain with an estab-
lished diagnosis of CS according to the International
Cowden Syndrome Consortium Operational Criteria1,
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She was first diagnosed with thyroid follicular carcinoma
and was treated with a thyroidectomy in 1989. The patient
then developed breast cancer in 1991 for which she
underwent lumpectomy followed by adjuvant radio-
chemotherapy. Due to local recurrence the following year,
she was treated with a left mastectomy and a few months
later she underwent right nephrectomy for renal carci-
noma. In 2003, she was diagnosed with left scapular renal
metastatic and during the same year she developed brain
metastases that required a right frontal lobe resection fol-
lowed by whole brain radiotherapy. On presentation, she
was known to have pulmonary and multiple bone metas-
tases. Palliative skeletal radiotherapy was completed hav-
ing exceeded the maximum radiation limits. As a last
resort, she was on interferon treatment as well as bisphos-
phonates for palliation therapy.
On clinical examination, the right hip was painful with a
restricted range of motion and she was unable to weight
bear. At the distal part of her right femur a pulsatile mass
could be felt but the knee had normal function with no
effusion. There was no neurovascular deficit detectable.
She scored 8 out of 10 in the visual analogue scale VAS for
pain (VAS-P) and 3 out of 10 in the quality of life Euro-
QolVAS (VAS-EQ) questionnaires[7]. The Harris Hip
Score[8] (HHS) was 46, the Beck Depression Index[9]
(BDI) 28, the State-Trait Anxiety Index[10] (STAI) was 69,
and she was given a score of 3 according to the American
Society of Anesthesiologists (ASA)[11]. Radiographs of
the pelvis and the entire right femur showed a destructive
osteolytic lesion of the femoral head and neck occupying
more than 50% of the bony mass with thinning of the
medial femoral neck cortex and a large osteolytic lesion in
the ipsilateral supracondylar region. Magnetic resonance
imaging (MRI) of the right femur revealed a 5.3 cm in
diameter bone metastasis within the distal femur which
was breaching the posterior cortex and encroaching on the
popliteal vessels (Figure 1, Figure 2 Figure 3). A vascular
metastatic extrusion in the suprapatellar pouch was also
detected (Figure 3). In addition, there was a similar lesion
at the level of the lesser trochanter with an ill-defined
intra-medullary component and marked cortical reaction
(Figure 1). A 2.4 cm mass within the right femoral head
extending into the subchondral bone and a second 3.5 cm
mass in the femoral neck of lower intensity in STIR coro-
nal views were also detected (Figure 2). MRI of the pelvis
revealed vascular metastatic lesions adjacent to the acetab-
ular roof and the posterolateral wall. The rest of the ipsi-
lateral ilium and ischium were intact. Laboratory tests
including a full blood count, renal, liver, thyroid function
tests, clotting profile and parathyroid hormone levels
were all within normal limits.
Surgical planning and technique
The two destructive osteolytic lesions of the right femur
scored more than 9, according to Mirels classification
[12]. An imminent pathological fracture in the proximal
and distal femur was thus diagnosed and a multi-discipli-
nary team meeting took place to discuss the management
of this case. The question of long-term survival was raised
but no definitive answer was given as the patient had sur-
vived this multiple neoplasia syndrome for over 20 years.
The dilemma of palliative prophylactic surgery was also
debated. The option of femoral nailing (ante- or retro-
grade) was ruled out due to lack of proximal bony support
(femoral neck and acetabular metastasis) and the pres-
ence of a distal vascular lesion (exophytic metastasis with
vascular MRI signal in the distal femur bridging both the
anterior and the posterior distal femoral cortices). Total
femoral replacement with a hinged constrained total knee
arthroplasty could provide a solution but meticulous ana-
tomical dissection close to the popliteal vessels would be
necessary and potentially hazardous. Above knee amputa-
tion was an option. However, healing of the stump and
loading of the limb would not improve her mobility and
quality of life since the metastatic disease was also affect-
ing the ipsilateral hip joint. The distal femur (Mirels clas-
sification score 11) was considered to have priority as an
imminent fracture was at greater risk compared to the
proximal femur (Mirels classification score 9). The patient
T1 weighted fat suppressed post gadolinium coronal views of the hole righ femuFigure 1
T1 weighted fat suppressed post gadolinium coronal 
views of the whole right femur. Vascular lesions are 
shown at the distal intercondylar femoral site and the proxi-
mal femur adjacent to the lesser trochanter.Page 2 of 5
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gery. Successful embolisation of the vascular lesions in the
acetabulum, proximal and distal femur was performed
twenty-four hours prior to surgery. On the operating table
the patient was placed in the lateral decubitus position to
allow access to both the distal femur and hip joint. A lat-
eral approach to the distal femur was first performed at
the level of the lesion and was extended to the femoral
condyles in order to allow positioning of a locking plate
at that level. The tumour was then approached from the
anterior femoral cortex above the patella and resected.
Following this, the locking plate was applied percutane-
ously and was measured in length to overlap proximally
the distal end of the cemented femoral prosthesis which
was implanted at a second stage. The distal femur was
then augmented by methylmethacrylate cement injection
to fill the void. No major bleeding was encountered and
the cement injection was controlled with continuous radi-
ographic imaging to prevent leakage into the popliteal
fossa. Subsequently, the hip joint was opened via a poste-
rior approach. A standard procedure with short rotators
and capsular tagging for repair was performed and a
cemented Exeter total hip arthroplasty using a long stem
(200 mm) was inserted. Meticulous curettage of the met-
astatic lesions from the acetabular and femoral medullary
site was also performed in order to debulk the metastatic
mass and replace it with cement. There was no cement
restrictor placed and the cement was pressurised to fill the
femoral canal as far distally as possible. Venting of the
femoral canal was performed through predrilled 4.5 mm
holes in the lateral cortex (Figure 4a, 4b, 4c). The patient
made an uneventful recovery and started fully weight
bearing within a week from surgery. The blood loss (total
estimated 700 mls) was within expectations and blood
transfusion was not necessary. Within the first 6 weeks the
HHS improved to 90, the BDI to 12, the STAI to 48, the
VAS-P to 3 and the VAS-EQ to 9. The post operative his-
topathological examination of the specimens retrieved
from the distal femur revealed metastatic renal cell carci-
noma. The femoral head and acetabular lesions were also
of renal origin whilst the femoral neck lesion was a breast
tumour metastasis. The patient continued interferon and
bisphosphonate treatment thereafter, and survived for a
year having a good quality of life and full mobility.
Discussion
Our patient presented with a long history of metastatic CS
resistant to radio-chemotherapy. We elected to proceed to
a combined surgical treatment of both the proximal and
distal femoral metastases leaving the unaffected mid
femur intact. A percutaneous plate fixation of the distal
femur with an intralesional excision and cementoplasty of
the metastasis was performed initially. This was combined
Coronal T2 weighted fat suppressed (STIR) view of the right hip j intFigure 2
Coronal T2 weighted fat suppressed (STIR) view of 
the right hip joint. Two different signals in the femoral 
neck. The most proximal was similar to subtrochanteric and 
distal femoral intercondylar signal most possibly of vascular 
origin. The most distal lesion was less vascular.
T1 fat suppression post gadolinium axial view of the distal femurFig e 3
T1 fat suppression post gadolinium axial view of the 
distal femur. The metastasis is bridging the anterior and the 
posterior femoral cortex and in places is in very close prox-
imity to the popliteal neurovascular structures.Page 3 of 5
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long revision stem and a cementoplasty of the femoral
canal. Weber et al[13] recommended curettage with
cementation and stabilization for metastatic renal cell car-
cinomas that are refractory to local adjuvants such as radi-
otherapy. They showed that this can decrease local
progression of the disease. The same authors also advised
embolization twelve to thirty six hours pre-operatively for
renal cell and thyroid carcinomas especially if the proce-
dure is performed without a tourniquet as in our case.
Recently Fuchs et al[14] reported no difference in the
long-term survival between wide resection and intrales-
sional curettage of renal cell metastases. However the
functional morbidity of a widespread resection and recon-
struction and its effect on weight-bearing should be con-
sidered and weighed against the potential prolongation of
survival. Cemented THA with long stem femoral implant
and cemented acetabular component are also recom-
mended for metastatic long bone disease. Uncemented
implants are contraindicated as the bone is biologically
inert following previous or adjuvant radiotherapy and
does not therefore allow ingrowth onto the implants[13].
Cardiopulmonary compromise and thromboembolic
events can be minimised by venting the femoral canal and
lowering cement pressurisation [15].
In our case, preoperative biopsy or intraoperative frozen
section biopsy were deemed unnecessary as the MRI fea-
tures of the metastatic lesions were vascular and therefore
of renal or thyroid origin.
Mirels classification system is a reliable method of predict-
ing the likelihood of a pathological fracture and was used
along with the clinical evaluation of the overall functional
status of the patient to guide our treatment[16]. We
believe that by preserving the femur we have maintained
the limb's functional capacity to a significant extent. That
would possibly not have been the case if a widespread
bone resection or a complex replacement reconstructive
procedure had taken place[17]. In addition to, our surgi-
cal approach allowed bone cementoplasty enhancement
avoiding major resections, excessive blood loss and a high
risk of postoperative infection.
Conclusion
This case reports on CS, a rare disease with multiple skel-
etal metastases of different origin. The treatment included
a combination of cemented arthroplasty, cementoplasty
and internal fixation that maintained function and
improved our patient's quality of life.
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(a) Anteroposterior view of the proximal femurFigure 4
(a) Anteroposterior view of the proximal femur. A 
long cemented Exeter total hip arthroplasty. There is no 
cement restrictor and the cement has been pressurized to 
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neous plating of the distal femur.
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